Experimental models and their use in studies of diabetic retinal microangiopathy

被引:0
作者
Bazan, NG
Gordon, WC
Marcheselli, VL
Lukiw, WJ
Duhault, J
Koenig-Berard, E
Linn, DM
DeCoster, MA
Mukherjee, PK
机构
[1] Louisiana State Univ, Med Ctr, Neurosci Ctr Excellence, New Orleans, LA 70112 USA
[2] Inst Rech Int Servier, F-92415 Courbevoie, France
来源
THERAPIE | 1997年 / 52卷 / 05期
关键词
diabetes mellitus; experimental models; retinal microangiopathy;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes produces dramatic changes in retinal microvasculature, triggering endothelial cell proliferation and microaneurysms. Capillaries become weakened, releasing blood into vitreal and retinal spaces. Photoreceptors become occluded and separated from the choriocapillaris, resulting in visual acuity decline, detachment and cell death. Several models have been developed that have proved useful for the study of this disease, resulting in a better understanding of the processes involved. Streptozotocin treatment affects the pancreatic beta cells, rapidly reducing them until insulin is no longer synthesized in sufficient amounts. The galactosemic model shifts metabolism away from glucose, increasing aldose reductase and retinal polyol metabolism. Finally, two weeks of cycled oxygen from high to low tension every 24 hours, followed by return to room air, triggers microangiogenesis in developing retinas. Use of these models, separately or in combination, as well as electroretinographic analysis, has begun to reveal the events taking place as diabetic retinopathy progresses. Endothelial cells become separated from pericytes as basement membranes thicken, and vascular endothelial growth factor increases, triggering their proliferation. Finally, early changes occurring within photoreceptors can now be studied.
引用
收藏
页码:447 / 451
页数:5
相关论文
共 28 条
[1]  
AKITA M, 1993, ACTA MED OKAYAMA, V47, P299
[2]   Diabetic retinopathy: Morphometric analysis of basement membrane thickening of capillaries in different retinal layers within arterial and venous environments [J].
Anderson, HR ;
Stitt, AW ;
Gardiner, TA ;
Archer, DB .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1995, 79 (12) :1120-1123
[3]  
Baudouin C, 1990, Ophtalmologie, V4, P53
[4]   CLASS-II ANTIGEN EXPRESSION IN DIABETIC PRERETINAL MEMBRANES [J].
BAUDOUIN, C ;
GORDON, WC ;
FREDJREYGROBELLET, D ;
BAUDOUIN, F ;
PEYMAN, G ;
GASTAUD, P ;
BAZAN, NG .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1990, 109 (01) :70-74
[5]  
BAZAN HEP, 1985, NEUROCHEM PATHOL, V3, P109
[6]  
BENNETT RA, 1981, CANCER RES, V41, P2786
[7]   EVALUATING RETINAL CIRCULATION USING VIDEO FLUORESCEIN ANGIOGRAPHY IN CONTROL AND DIABETIC RATS [J].
BURSELL, SE ;
CLERMONT, AC ;
SHIBA, T ;
KING, GL .
CURRENT EYE RESEARCH, 1992, 11 (04) :287-295
[8]  
CALDWELL RB, 1992, INVEST OPHTH VIS SCI, V33, P1610
[9]  
CRINGLE SJ, 1993, INVEST OPHTH VIS SCI, V34, P1716
[10]   Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization [J].
Hammes, HP ;
Brownlee, M ;
Jonczyk, A ;
Sutter, A ;
Preissner, KT .
NATURE MEDICINE, 1996, 2 (05) :529-533